Viewing Study NCT06955260


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2025-12-26 @ 12:40 AM
Study NCT ID: NCT06955260
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-02
First Post: 2025-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure
Sponsor: Subodh Verma
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-05
Start Date Type: ESTIMATED
Primary Completion Date: 2027-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-03
Completion Date Type: ESTIMATED
First Submit Date: 2025-03-15
First Submit QC Date: None
Study First Post Date: 2025-05-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-04-24
Last Update Post Date: 2025-05-02
Last Update Post Date Type: ACTUAL